Anudeep Polam

Anudeep Polam has worked in a variety of roles in the pharmaceutical industry since 2012. In that year, they began as a Chemistry Lab Technician at Cleveland State University, where they maintained standards of hygiene in freshman chemistry laboratories and prepared solutions for the labs. In 2015, they began working as an Analytical Scientist at Saptalis Pharmaceuticals, LLC, where they conducted method development for diffusion studies of semi-solid dosage forms and developed and validated analytical methods for active, impurities, and preservatives in semi-solid and liquid dosage forms. That same year, they also began working as a Quality Control Chemist at Bactolac Pharmaceutical Inc., where they performed dissolution studies followed by HPLC analysis and tested physical properties of finished products. In 2018, they began working as a Research and Development Chemist at Pii (Pharmaceutics International, Inc.), where they conducted analytical deficiency response studies for drug products and designed and executed pre-formulation studies. Most recently, in 2021, they began working as a Scientist II in Analytical and Formulations Development at Tarveda Therapeutics, where they perform qualitative and quantitative analysis of raw material, intermediates, finished product, and in-house drug substance and drug product stability samples using analytical instrumentation, and performs in-use stability studies to support IV drug delivery systems and qualify components of the infusion systems.

Anudeep Polam obtained a Bachelor's Degree in Pharmaceutical Sciences from Jawaharlal Nehru Technological University in 2011. Anudeep then went on to earn a Master's Degree in Analytical Chemistry from Cleveland State University in 2015.